| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |